Morgan Lewis represented Merck in the transaction. Merck closed its exclusive license and collaboration agreement with Kelun-Biotech, a holding subsidiary of Sichuan Kelun Pharmaceutical Co. Ltd., to...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here